This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Analysts initiated coverage: Neutral on KEEL ($2), Buy on PTN ($12), FRVO ($17) and YARW ($60).
Stocks · News reference
8-K filing — NUSCALE POWER Corp (SMR)
Filed: 2026-11-05 AccNo: 0001822966-26-000089 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
NuScale Power Corporation Reports Third Quarter 2026 Financial Results
NuScale Power Corporation filed its 10-Q quarterly report for the period ending September 30, 2026, reporting revenue of $281,000 and a net loss of $45.7 million.
This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Analysts initiated coverage: BMO rated Astera Labs Outperform with a $375 target; Citi rated ATI Buy with a $229 target.
The Zacks Analyst Blog Highlights Oklo, Talen Energy and NuScale Power
Zacks analysts discuss three advanced nuclear energy companies ahead of earnings. Oklo Inc. is set to report Q3 2026 results with expected $2.2M in revenue but continued losses. The analysis highlights long-term growth potential from Aurora projects and supply chain expansion, but warns of near-term challenges including rising expenses, higher capital spending, and a history of earnings misses. Investors are cautioned to consider reducing exposure rather than initiating new positions.
Wedbush Initiates Coverage of NuScale Power with Underperform Rating
Wedbush analyst Seth Basham initiated coverage of NuScale Power Corporation with an 'Underperform' rating and a $5 price target, citing concerns over the company's commercial progress.
Barclays Turned Bearish on NuScale Power at a 52-Week Low. Here's the Single Missing Contract That Would Prove It Wrong.
NuScale Power's stock has declined 85% from its 52-week high, prompting Barclays to reduce its price target from $11 to $5. The company has achieved regulatory approval for its small modular nuclear reactor design but lacks a signed customer contract, which is critical to validate its business model. NuScale is burning through cash while awaiting potential deals with RoPower in Romania and ENTRA1 Energy in the U.S., with negotiations expected to extend into early 2027.